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Abstract
Background: The use of global gene expression profiling is a well established approach to understand biological
processes. One of the major goals of these investigations is to identify sets of genes with similar expression
patterns. Such gene signatures may be very informative and reveal new aspects of particular biological processes.
A logical and systematic next step is to reduce the identified gene signatures to the regulatory components that
induce the relevant gene expression changes. A central issue in this context is to identify transcription factors, or
transcription factor binding sites (TFBS), likely to be of importance for the expression of the gene signatures.
Results: We develop a strategy that efficiently produces TFBS/promoter databases based on user-defined criteria.
The resulting databases constitute all genes in the Santa Cruz database and the positions for all TFBS provided by
the user as position weight matrices. These databases are then used for two purposes, to identify significant TFBS
in the promoters in sets of genes and to identify clusters of co-occurring TFBS. We use two criteria for significance,
significantly enriched TFBS in terms of total number of binding sites for the promoters, and significantly present
TFBS in terms of the fraction of promoters with binding sites. Significant TFBS are identified by a re-sampling
procedure in which the query gene set is compared with typically 10
5 gene lists of similar size randomly drawn
from the TFBS/promoter database. We apply this strategy to a large number of published ChIP-Chip data sets and
show that the proposed approach faithfully reproduces ChIP-Chip results. The strategy also identifies relevant TFBS
when analyzing gene signatures obtained from the MSigDB database. In addition, we show that several TFBS are
highly correlated and that co-occurring TFBS define functionally related sets of genes.
Conclusions: The presented approach of promoter analysis faithfully reproduces the results from several ChIP-Chip
and MigDB derived gene sets and hence may prove to be an important method in the analysis of gene signatures
obtained through ChIP-Chip or global gene expression experiments. We show that TFBS are organized in clusters
of co-occurring TFBS that together define highly coherent sets of genes.
Background
The use of global gene expression profiling is a well
established approach to characterize biological states or
responses. One of the major goals of these investigations
is to identify sets of genes with similar expression pat-
terns that may shed new light on the underlying biologi-
cal process leading to the observed states. A logical and
systematic next step is to reduce the identified gene sig-
natures to the regulatory components that induce the
relevant gene expression states, with the over all goal to
identify the gene regulatory network in operation. A
central issue in this context is to identify transcription
factors, or transcription factor binding sites, likely to be
of importance for the expression of the gene signatures.
A constructive approach in this direction has been to
combine information on specific transcription factor
binding sites (TFBS) with information on gene co-
expression as determined by global gene expression
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tive TFBSs in a set of gene promoters. This is normally
accomplished by searching the DNA sequence for
matches to generalized sequence patterns obtained from
experimentally characterized binding sites. These
sequence patterns are represented in the form of posi-
tion weight matrices (PWM) that describe the probabil-
ity distribution of the four possible nucleotides at each
location in the motif sequence. Several softwares such as
MATCH [1], MatInspector [2], and TESS [3] use PWMs
obtained from JASPAR [4] or TRANSFAC [5] - large
and frequently updated databases that contain PWMs -
to identify possible binding sites. An inherent problem
with TFBS searches is that the binding motifs are short
and degenerate which lead to high error rates in gen-
ome-wide scans. One approach to reduce the error rate
is to limit the search to evolutionarily conserved seg-
ments or to evolutionarily conserved binding sites only.
In addition, when working with sets of coordinated
g e n e st h es e a r c hm a yb er e s t r i c t e dt oT F B Ss h a r e db y
all members in the gene set, or show over-representa-
tion. Hence, a productive method has been to select
genes that are significantly changed or show coordinated
expression, and then identify over-represented TFBSs in
the promoters of the selected genes. For example, in the
TOUCAN software [6] Markov background models are
used to identify significant binding sites analytically and
a parametric statistical algorithm to estimate enrich-
ment, whereas in the CONFAC software [7] evolutiona-
rily conserved binding sites are considered significant
and TFBS enrichment is evaluated by a non-parametric
statistical test using a fixed set of reference random
gene lists. An alternative approach to include gene
expression analyses in the protocol is to produce gene
sets based on shared TFBS and investigate the extent to
which genes in the sets show co-expression in published
gene expression data [8]. An extension of this approach
is to score all genes for high quality TFBS and then
investigate to what extent TFBS co-occur with the aim
to identify genes that show a high probability to be
regulated by the same sets of transcription factors. In
these latter approaches efficient means to produce lists
of possible target genes is necessary. In the present
investigation we develop a strategy that efficiently pro-
duces TFBS/promoter databases. The resulting TFBS/
promoter databases constitute all genes in the Santa
Cruz database and the positions for all TFBS provided
by the user as PWMs. These databases are then used
for two purposes, to identify significant TFBS in the
promoters of gene sets and to identify clusters of co-
occurring TFBS on a genome-wide scale. In the first
application significant TFBS are identified by a re-sam-
pling procedure in which the query gene set is com-
pared with typically 10
5 independent gene lists of
similar size randomly drawn from the TFBS/promoter
database. For these purposes two criteria for significance
are used; significant enrichment and significant pre-
sence. We apply this strategyt ob o t hp u b l i s h e dC h I P -
Chip data and to curated gene signatures obtained from
the MSigDB database. In the second application, we
show that several groups of TFBS are highly correlated
and that correlated TFBS define functionally related sets
of genes.
Results
Creating TFBS/promoter databases
To generate TFBS/promoter databases we developed the
SMART (Systematic Motif Analysis Retrieval Tool) soft-
ware. The SMART software contains an application to
download RefSeqs, mRNA information, and promoter
regions from the UCSC Genome browser database to a
local MySQL database, and hence reduce the need for
frequent interactions with the UCSC Genome browser
database. The SMART software then retrieves each pro-
moter sequence from the local database followed by
scanning for transcription factor binding sites. In this
study we used PWMs from the TRANSFAC v2009.1
database [5]. For the first TFBS/promoter database, core
similarity score (CSS) threshold values of 1.0 and matrix
similarity score (MSS) threshold values of 0.9, were used
to identify putative TFBS [1]. All hits of TFBS for the
same transcription factor, e.g., MYC_01, MYC_02, and
MYC_03, in a given promoter region were then summed
up. A first TFBS/promoter database was produced using
promoter sequences consisting of the - 1500 to +500
genomic interval relative putative TSSs, using the start
of the RefSeq or the mRNA with the most distal TSS
for each gene. Then a second TFBS/promoter database
aimed for phylogenic foot printing analyses was created
by using the corresponding orthologous genes listed in
the NCBI HomoloGene database based on human and
mouse. For each orthologous gene pair the evolutiona-
rily conserved sequences within the - 5000 to +1000 bp
relative the TSS were identified using the BLAST pro-
gram and the criterion e < 0.001, and TFBS identified as
above. In the present investigation the -1500 to +500 bp
TFBS/promoter database is composed of 18 377 genes
and the - 5000 to +1000 bp database of 13 117 genes.
Estimations of significance using TFBS/promoter
databases as references
We use two measures of significance to identify TFBS
likely to be involved in the regulation of the query gene
sets; significant enrichment (E); an estimation of TFBS
over-abundance in a query gene list, and significant pre-
sence (P); an estimation of TFBS promoter over-pre-
sence in a query gene list. TFBS enrichment analysis is
based on the observation that genes regulated by a given
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factor in their respective promoter regions. To calculate
E the total number of instances of a given TFBS in the
promoters of genes in a query gene list is recorded.
Then the TFBS/promoter database is re-sampled with
replacement to produce randomly selected and indepen-
dent gene lists with the same number of genes as in the
query list. The number of TFBS instances in each re-
sampled gene list is recorded and then ranked according
to the number of TFBS present (the gene list with the
largest number of instances = rank 1) together with the
results for the query list. The rank of the query gene list
divided by the total number of re-sample instances is
then used as a p value for the probability to acquire the
level of enrichment by chance (PE). The PE value is then
transformed into a score by using the -Log(PE)v a l u e .
Assuming that all genes in a given query list are regu-
lated by a given transcription factor TFA,o n ew o u l d
expect that each gene promoter contains at least one
binding site for TFA. The chance to find one instance of
a given TFBS in a promoter is however dependent on
the frequency of the corresponding sequence motif in
promoters. We therefore introduce the “significant pre-
sence” measure which is an estimate of the probability
(PP) to find the observed number of promoters with at
least one instance of the TFBS in a randomly selected
gene list of the same length as the query list. The PP is
estimated by a resampling procedure similar to the esti-
mation of PE, and is converted to a score by using -Log
(PP). The fraction of genes (%-presence) in the query list
that contain at least one instance of a given TFBS is
also recorded.
Gene set promoter analysis
To validate the promoter analysis strategy it was first
applied to published ChIP-Chip data and then curated
gene sets from MSigDB. The rationale of using ChIP-
Chip data is that such data is expected to identify gene
promoters that a given transcription factors interact
with physically. The results are either evaluated by a
table containing values for PE,P P, and %-presence,
respectively, or by score graphs produced by plotting
the -Log(PE), -Log(PP), and %-presence, in any combina-
tion. An example of a -Log(PE)/-Log(PP)g r a p hi sg i v e n
in Figure 1A in which the promoters of genes reported
by Boyer et al. to bind E2F4 by ChIP-Chip analysis
(BOYER_E2F4) have been analyzed using the -1500 to +500
bp surrounding the TSS’s and a total of 10
6 re-samples. The
analysis identified the TFBS E2F, E2F1, E2F1DP1,
E2F4DP2, E2F, E2F1DP1RB and E2F1DP2, among others,
as both significantly enriched and significantly present with
E and P scores of 6 in each case (Table 1). In Figure 1B a
three dimensional representation of the data is shown
based on the -Log(PE) and -Log(PP) scores, and %-presence.
This latter graph identifies E2F, E2F1, CBF, ETF, WHN,
VMYB, ELK1, and CETS1P54 as highly significant binding
sites.
Apart from data on E2F4 binding sites Boyer et al.
also reported ChIP-Chip data on NANOG, OCT4, and
SOX2 binding sites. As no definite PWM exists for
SOX2 in the TRANSFAC database no analyses of this
binding site were performed. The analyses of the genes
reported to bind NANOG or OCT4 using -1500 to +500
portions of the promoters did not indicate any binding
sites for the NANOG and OCT related transcription fac-
tors as significant. We then applied a phylogenic foot
printing approach using the -5000,+1000 portions of the
promoters (Additional file 1, Figure S1A and B). In this
case, NANOG and OCT related binding sites were
among the top ranking binding sites with respect to
E- and P-scores in the BOYER_NANOG and the BOY-
ER_OCT4 data sets respectively. NANOG showed E- and
P-scores of 4.7 and 5, respectively, and the OCT related
binding sites OCT4, OCT1, and OCT all showed maxi-
mum E- and P-scores of 5 when using 10
5 re-samples.
Hence in this case positive data was only obtained when
limiting the analysis to evolutionarily conserved segments
of the promoters. The analysis of the BOYER_NANO-
G_OCT4_SOX2 data set, that contains genes that bind
all three transcription factors, produced top ranking
E- and P-scores for the OCT related bindings site
whereas the NANOG site showed moderate significance
when using the phylogenetic foot printing approach. On
the other hand, the OCT binding sites showed top scores
in the BOYER_NANOG data set (blue in Additional file
1, Figure S1A) and conversely, NANOG showed top
scores in the BOYER_OCT4 data set (blue in Additional
file 1, Figure S1B), indicating, as expected, a significant
overlap in the binding sites for these two transcription
factors. In addition to the BOYER_E2F4 data we also
analyzed the XU_E2F ChIP-Chip data using a 10
6 resam-
pling procedure in which E2F1, E2F1DP1, E2F4DP2,
E2F1DP1EB TFBS all obtained maximum E- and
P-scores, i.e. equal to 6. The SMEENK_TP53 ChIP-Chip
data did not give as clear cut results as the previous
ChIP-Chip data. The promoter analysis of TP53 binding
genes resulted in the top ranking E-score (~3.3) but not
the top ranking P-score for TP53 (Additional file 1, Figure
S1C) even though the TP53 binding motif was present in
71% of the promoters (Additional file 1, Figure S1D).
We analyzed the ZELLER_MYC ChIP-Chip data in
three different ways. First all genes reported to bind
MYC, then the genes that bind MYC but lack the Ebox,
and then the genes that bind MYC and contain an Ebox
were included in the analysis. In the first analysis the
MYCMAX binding site was the most significant both
with respect to E- and P-scores (Additional file 2, Figure
S2A). The same analysis of MYC binding genes lacking
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binding sites (Additional file 2, Figure S2B), whereas the
analysis of Ebox containing genes showed significant E-
and P-scores for all MYC related binding sites (Addi-
tional file 2, Figure S2C). In fact all six, NMYC, MYC-
MAX, MAX, MYC, MAX, and CMYC, as well EBOX,
showed maximum E- and P-scores of 5. In a subsequent
analysis using a 10
6 re-sample approach NMYC, MYC-
MAX, MAX, and CMYC, as well as EBOX binding sites
obtained maximum E- and P-scores of 6, underscoring
the enrichment of these sites in the promoters of MYC
binding genes with Eboxes (Additional file 2, Figure
S2D). As this analysis was limited to the -1500 to +500
regions of the promoters one may tentatively conclude
that Ebox containing genes preferentially show MYC
binding sites in the close vicinity of the TSSs whereas
genes lacking Eboxes may bind the MYC transcription
factors outside the -1500,+500 regions, or use an as yet
not identified binding motif.
We then analyzed the ODOM_HNF6_Hepa and
ODOM_HNF6_Panc ChIP-Chip data, Figure 2A and 2B.
In both sets of genes HNF6 binding sites showed top-
ranking E- and P-scores and were detected in 45% of the
promoters in the Hepa and Panc gene sets respectively
(Figure 2C and 2D). Interestingly, the binding sites
CDPCR3HD and CDPCR1 both showed maximum E-
and P-scores in both data sets. These sites were present
in 18 and 21% in the HNF6-Hepa and HNF6-Panc
promoters, respectively, indicating these as possible co-
factors in a sub set of the genes. The data also indicated
the possible role for HOXA3 in the regulation of this set
of genes. HOXA3 was present in 84% of the promoters
from both cell types and was among the top ranking
binding sites with respect to E- and P-scores in both the
Hepa and the Panc sets of HNF6 binding genes.
To further explore the strategy we analyzed gene sig-
natures obtained from the MSigDB database associated
with induced expression of various transcription factors
or processes (hypoxia) known to involve specific tran-
scription factors. We downloaded four gene sets related
to MYC gene expression, FERNANDEZ_MYC_TAR-
GETS, MYC_ONCOGENE_SIGNATURE, MYC_TAR-
GETS, and LEE_MYC_UP. The genes in the respective
gene sets were analyzed in the -1500,+500 portions of
the promoters using a 10
5 resampling procedure (Figure
3). All MYC related binding sites, MYCMAX, MYC,
NMYC, CMYC, MAX, and EBOX, showed maximum
E- and P-scores (equal to 5) in the FERNANDEZ_-
MYC_TARGETS and all but MYCMAX in the
MYC_ONCOGENE_SIGNATURE gene set. All but
CMYC showed maximal E scores in the MYC_TAR-
GETS gene set whereas the P scores were moderate but
still among the top ranking. None of the MYC related
binding sites showed high scores in the LEE_MYC_UP
gene set, in fact all of them showed E- and P-scores
below 1. A possible explanation for the negative results
Figure 1 Promoter analysis of genes binding E2F4 as determined by ChIP-Chip analysis. Estimations of PE and PP based on 10
6 re-samples
and the -1500,+500 portions of the promoters. A) TFBS E-score plotted against P-score. Insert; list of binding sites with maximum -Log(PE) and
-Log(PP), motifs in red; motifs with ≥ 80% presence, B) a three dimensional representation of the results with E-score on the x-axis, P-score on
the y-axis, and %-presence on the z-axis. Insert, motifs with -Log (PE) and -Log(PP) equal to 6 and showing ≥ 80% presence.
Veerla et al. BMC Genomics 2010, 11:145
http://www.biomedcentral.com/1471-2164/11/145
Page 4 of 17obtained for the LEE_MYC_UP signature could be that
this signature is dominated by late/secondary MYC tar-
gets not directly regulated by the MYC protein. An indi-
cation that this may be the case was the finding that
only 27% of the promoters in the LEE_MYC_UP gene
set contained EBOX motifs whereas these were seen in
70% of the promoters in the FERNANDEZ_MYC_TAR-
GETS gene set. Essentially the same results were
obtained when repeating the analysis using the phylo-
genic foot printing approach, including the negative
results for the LEE_MYC_UP gene set (Additional file 3,
Figure S3). We performed similar analyses of four
hypoxia related gene signatures (Figure 4). The HIF1
binding site was the single site that showed maximum
E/P scores in the MENSE_HYPOXIA_UP gene set. The
HIF1 site showed the top ranking E-score and was
among the top ranking with respect to the P-score in
the HIF1_TARGETS gene set, showed moderate E- and
P-scores (3 to 4) in the HYPOXIA_NORMAL_UP gene
set, and showed low scores (<3) in the MANALO_HY-
POXIA_UP gene set. Hence, the analysis indicated HIF1
a st h em o s ti m p o r t a n tb i n d i n gs i t ei nt w oo ft h eg e n e
sets. Repeating the analysis using the phylogenic foot
printing approach further emphasized the importance of
HIF1 sites, particularly in the HYPOXIA_NORMAL_UP
gene set, but did not improve the results for the MAN-
ALO_HYPOXIA_UP set of genes (Additional file 4, Fig-
ure S4). As for the LEE_MYC_UP signature, the poor
results for the MANALO_HYPOXIA_UP gene set could
p o s s i b l yb ee x p l a i n e db yt h ep r e s e n c eo fah y p o x i al a t e
response signature. We also noticed that whereas the
HIF1 site was one of the top ranking TFBS in all the
MYC signatures investigated that also showed MYC
t a r g e t sa st o p - r a n k i n g ,M Y CT F B S sw e r en o tt o p - r a n k -
ing in the hypoxia related signatures. The HINA-
TA_NFKB_UP gene set showed top ranking E- and
P-scores for the NFKB, NFKAPPB, and NFKAPPB65
binding sites using the -1500,+500 regions (Figure 5A).
The NFKAPPB50 motif was however not significant.
The importance of the NFKB related TFBS for this set
of genes was further emphasized using the phylogenic
foot printing approach (Figure 5B). Poor results were
however obtained for the HANSON_NFKAPPB_IND
gene set using both approaches (Figure 5C and 5D).
The analysis of the KANNAN_TP53_UP gene signature
indicated P53 as the most significantly enriched binding
site with an E-score close to 4. Even though the P-score
was non-convincing (~1), the TP53 site was present in
close to 80% of the promoters. This type of results i.e.,
moderate E-Scores and low P-scores but high %-pre-
sence, was also obtained for the SMEENK_TP53 ChIP-
Chip data and indicates that TP53 binding sites are fre-
quently seen in promoters albeit at low numbers for
each promoter. Additional MSigDB signatures that per-
formed well were E2F3_ONCOGENETIC_SIGNATURE
generating E- and P-scores of 5 for E2F1, E2F, and
E2F1DP1RB site, respectively; HALMOS_CEBP indicat-
ing CEBP and CEBPGAMMA as the two top two bind-
ing sites with respect to E- and P-scores when applying
phylogenic foot printing, and the BILD_MYC signature,
that included EBOX, MYC, MAX, CMYC, and MYC-
MAX among the top ten ranking together with USF,
USF2, HIF1, ARNT, and CLOCKBMAL, and BIL-
D_E2F3, that included E2F1, E2F, E2F1DP1, and
E2F1DP1RB among the 15 binding sites with E- and P-
scores equal to 5.
Identification of sets of co-occurring TFBS and defining
TFBS based gene signatures
It is well established that most transcription factors do
not act in solitude but in a cooperative fashion with
other factors. Hence, co-regulated genes are expected to
share more than one TFBS in their promoters, as was, e.g.,
seen in the above analyses of the MSigDB gene sets. To
gain new knowledge on such possible combinations
we used the -1500 to +500 TFBS/promoter database to
Table 1 TFBS E and P scores for the BOYER_E2F4 data
TFBS E Score P score %-presence
E2F 6.00 6.00 97.1
CETS1P54 6.00 6.00 96.7
ETF 6.00 6.00 96.7
CBF 6.00 6.00 93.6
ELK1 6.00 6.00 92.0
WHN 6.00 6.00 92.0
E2F1 6.00 6.00 87.6
VMYB 6.00 6.00 79.9
E2F1DP1 6.00 6.00 57.7
E2F4DP2 6.00 6.00 57.7
PAX8 6.00 6.00 52.9
E2F1DP1RB 6.00 6.00 40.5
E2F1DP2 6.00 6.00 28.3
CREBATF 6.00 5.05 77.0
CREB 6.00 5.00 77.2
ATF 6.00 4.77 76.5
AHRARNT 6.00 4.55 84.1
AHR 6.00 4.15 92.9
AHRHIF 6.00 4.07 92.9
ZF5 4.07 6.00 90.3
SP1 3.57 6.00 96.2
CAAT 6.00 2.59 67.3
GC 2.23 6.00 80.8
AP2ALPHA 2.20 6.00 94.9
CHCH 1.60 6.00 97.6
AP2GAMMA 0.86 6.00 85.8
NF1 5.30 0.58 98.0
STAT1 6.00 0.45 100.0
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number of instances for each TFBS in each promoter as
variables. This matrix was subsequently re-ordered using
hierarchical clustering analysis (HCA; Additional file 5,
Figure S5). The obtained re-ordered correlation matrix
d i di n d e e ds h o wd i s t i n c tf e a t u r e s .A p a r tf r o mT F B S ’s
showing strong and significant correlations, a portion
of the TFBS showed no or very low correlations. In
Figure 6 the analysis has been limited to subset of TFBS
that showed the most varying correlations (indicated in
Additional file 5, Figure S5). Based on the hierarchical
clustering several tentative groups of co-occurring TFBS
could be defined (Figure 6 and 7). Interestingly, strong
negative correlations were also detected in the data, par-
ticularly between the TEF1_BACH1, DBP_GATA, and
FREAC_HFH clusters and the GC_WHN and MAZR_IK
TFBS clusters suggesting a selection against the co-
occurrence of these groups of TFBS in gene promoters.
No negative correlations were however detected when
the analysis was repeated using the evolutionarily con-
served portions of the -1500,+500 promoter regions (data
not shown).
Figure 2 Promoter analysis of genes binding HNF6 as determined by ChIP-Chip analysis. Estimations of PE and PP based on 10
6 re-
samples and the -1500,+500 portions of the promoters. A) Results for HNF6 binding genes in hepatocytes, ODOM_HNF6_Hepa B) Results for
HNF6 binding genes in pancreatic cells, ODOM_HNF6_Panc. C) Results for ODOM_HNF6_Hepa plotted with E-score on the x-axis and
%-presence on the Y-axis. D) Results for ODOM_HNF6_Panc plotted with E-score on the x-axis and %-presence on the Y-axis.
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correlated TFBS as defined by the HCA. To evaluate the
coherence of the top ranking genes in the respective gene
lists the top 2000 genes were analyzed for GO category
enrichment. Of the 18 TFBS clusters listed in Figure 8,
twelve showed significant enrichment (Bonferroni cor-
rected p < 0.05) of gene ontology terms (Table 2 and
Additional file 6, Table S1). Hence, most of the TFBS
based gene signatures were significant for specific
biological processes, including as diverse processes as reg-
ulation of transcription, intracellular signaling cascade,
and immune response. The above analysis was repeated
with the TFBS/promoter database based on phylogenic
foot printing and the -5000,+1000 portions of the promo-
ters. Again several clusters of co-occurring TFBS was
identified and the most varying TFBS were selected for
further analysis (indicated in Additional file 7, Figure S6).
The subsequent HCA identified 26 TFBS clusters
Figure 3 Promoter analysis of MYC gene signatures obtained from MSigDB using the -1500,+500 portions of the promoters and 10
5
re-samples for estimations of PE and PP. A) Results for the FERNANDEZ_MYC_TARGETS signature. Insert, motifs with maximum -Log(PE) and
-Log(PP) values, MYC related motifs in red, B) Results for the MYC_ONCOGENE_SIGNATURE signature. Insert, motifs with maximum -Log(PE) and
-Log(PP) values, MYC related motifs in red C) Results for the MYC_TARGETS signature. Insert, motifs with maximum -Log(PE) and -Log(PP) values,
MYC related motifs in red d) Results for the LEE_MYC_UP signature. MYC related motifs in red. All signature designations are as in MSigDB.
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ment of specific GO categories (Additional file 8,
Table S2). These included top ranking GO categories as
diverse as regulation of transcription, cell adhesion, and
neurogenesis.
There are arguments for using relatively short intervals
as the definition of a promoter as well as for longer
intervals but then limit the analysis to evolutionarily
conserved regions. Both approaches have advantages
and limitations. The above analyses of ChIP-Chip and
MSigDB gene signatures, as well as that of co-occurring
TFBS, show that similar but not always identical results
may be obtained using either approach. To capitalize on
the benefits of both approaches we produced a third
TFBS/promoter database that takes into consideration
the -1500,+500 portions of the promoters as well as the
-5000 to -1500 and the +500 to +1000 evolutionarily
conserved portions. This produced a TFBS/promoter
database consisting of 13 096 genes. We used this data-
base to identify co-occurring TFBS using the QT-clust
algorithm, a more stringent method than manual
inspection of HCA dendrograms. This algorithm pro-
duced 58 groups of at least two co-occurring TFBS
(Table 3 and Additional file 9, Table S3). Many of these
Figure 4 Promoter analysis of hypoxia related gene signatures obtained from MSigDB using the -1500,+500 portions of the
promoters and 10
5 re-samples for estimations of PE and PP. A) Results for the MENSE_HYPOXIA_UP signature. B) Results for the
HIF_TARGETS signature. C) Results for the HYPOXIA_NORMAL_UP signature. Insert, motifs with maximum -Log(PE) and -Log(PP) values. D) Results
for the MANALO_HYPOXIA_UP signature. All signature designations are as in MSigDB.
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identified by the less stringent HCA approach. As above,
ranked gene list based on the normalized number of
TFBS hits in each gene promoter were produced and the
top 1300 genes in each TFBS gene signature were sub-
jected to analysis using the Ingenuity software. In Table 4
results obtained for the Ingenuity categories “Molecular
and Cellular Functions”, “Physiological System Develop-
ment and Function” and “Top Canonical Pathways” are
listed for 10 of the most biologically coherent TFBS clus-
ters. Intriguingly, of the 10 TFBS clusters in Table 4,
three were involved in “Nervous System Development” or
“Function and Axonal Guidance Signaling” and five in
immune response, which may indicate that these pro-
cesses are orchestrated by a several combinations of tran-
scription factors. Taken together, both the HCA and the
QT-clust formed clusters of co-occurring TFBS that
defined gene signatures with distinct biological properties.
Discussion
The backbone of the present investigation is the construc-
tion of the TFBS/promoter databases that we used for two
Figure 5 Promoter analysis of the HINATA_NFKB_UP and HANSON_NFKAPPB_IND gene signatures using 10
5 re-samples for
estimations of PE and PP. Results for the HINATA_NFKB_UP signature using A) the -1500,+500 portions of the promoters and B) using
phylogenic foot printing and the -5000,+1000 portions of the promoters. Results for the HANSON_NFKAPPB_IND signature using C) the -1500,
+500 portions of the promoters and D) using phylogenic foot printing and the -5000,+1000 portions of the promoters. NFKB related motifs in
red. All signature designations as in MSigDB.
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Page 9 of 17purposes; as a background files when analyzing promoters
for significant TFBS and as possible sources for investigat-
ing relationships among TFBS. As the definition of a pro-
moter may vary from type of investigation and scientific
questions asked, an advantage of the presented tool is that
variant TFBS/promoter databases may be produced read-
ily. In the present investigation we used three types of
databases each based on different promoter definitions;
regions derived from short segments upstream of the TSS,
conserved regions derived from large upstream segments,
and a combination of these two. We used two measures
for significance, significantly enriched (E) and significantly
present (P) TFBS, and rank statistics based on a resam-
pling procedure to estimate the corresponding p-values.
The E and P measures capture two aspects of TFBS signif-
icance, the recognition that genes regulated by a specific
transcription factor tend to have several recognition sites
for that particular factor and that genes regulated by a spe-
cific transcription factor are expected to have at least one
binding site each for that factor. The advantage of estimat-
ing p-values by a re-sampling method is that no assump-
tions regarding the underlying distribution of TFBS or of
promoter DNA sequences has to be made. Even though
we used a simple rule to score promoters (genes), i.e., the
Figure 6 Identification of correlated TFBS as identified using the -1500,+500 portions of the promoters. A hierarchical cluster analysis
with adjoined heat map of correlations of the portion of the TFBS that showed sizeable correlations and indicated in Additional file 5, Figure S5.
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Page 10 of 17number of high scoring motifs per promoter, biologically
relevant and intriguing results were obtained. Further-
more, as we use gene sets as the unit for investigation, and
not individual promoters, the inclusion of false positive
sites for individual genes identified with PWMs will have
limited effect on the final results. We showed that the pre-
sented strategy could faithfully reproduce several ChIP-
Chip results, and hence validate the strategy. Nonetheless,
there were some ChIP-Chip data that the strategy could
not reproduce, e.g., Palomero et al. [9] (TAL1 targets) and
Reed et al. [10] (SREBP1 targets). There might be more
than one explanation for these discrepancies, e.g., ChIP-
Chip data most likely contain false positives to a varying
degree and the PWM database employed, TRANSFAC,
may not be complete. An indication that the latter may be
the case is the fact that several ChIP-Chip and ChIP/PET
investigations have led to the discovery of new consensus
binding sites e.g., both Smeenk et al. [11] and Wei et al.
[12] present new TP53 motifs based on whole genome
ChIP analyses. It is thus likely that future ChIP-Chip and
ChIP/PET analyses will describe additional motifs for
other transcription factors as well. Discrepant results for
MSigDB derived gene signatures may be caused by several
factors. Apart from the fact that not all possible PWMs
may be present in the TRANSFAC database, an additional
complication is that the response to a given perturbation
may vary with the experimental procedures used, e.g., the
gene signature response may vary with time and thus
include secondary targets to varying degrees. An additional
factor that may reduce the E- and P-scores is that most
signatures in MSigDB have been obtained by micro array
experiments in which not all possible genes were included
in the analysis. Consequently, estimations by rank statistics
using the whole genome as a reference, as was performed,
may underestimate and skew the actual E- and P-scores.
Moreover, in some instances it may be beneficial to use a
reference matched to some characteristics of the gene sig-
nature, e.g., GC-content [13]. Nonetheless, several of the
gene signatures from the MSigDB produced consistent
results, again showing the strength of the proposed
strategy.
Apart from using the TFBS/promoter databases as
references when performing promoter analyses the data-
bases were also used as a source for investigating TFBS
co-occurrences. Using hierarchical cluster analysis we
were able to detect several clusters of TFBS. Similar,
and often identical, clusters of TFBS were obtained
when applying the phylogenic foot printing approach as
well as when we used the hybrid TFBS/promoter data-
base and an alternative clustering principle. This indi-
cates that the observed TFBS clusters are to a certain
level robust and not dependent on the algorithms used
to detect them. Some of the obtained TFBS clusters
were most likely caused by the presence of overlapping
binding motifs, e.g., the AML and MYC TFBS clusters,
whereas others may represent true co-occurrence in the
sense that the DNA sequence of the binding motifs are
unrelated. As no criterion for proximity, i.e., minimum
Figure 7 Identified clusters of TFBS using the -1500,+500 portions of the promoters. Color codes listed in the order left to right as in the
dendrogram in Figure 6.
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Page 11 of 17distance between TFBS, was used many of the identified
TFBS patterns are less constrained than so called TFBS
modules, typically 100-300 bp in size. The obtained
results thus suggest that long distance but within pro-
moter combinatorics may operate among transcription
factors. Interestingly, some clusters of TFBS showed
negative correlations. The negative correlations were
however lost when the analyses were limited to the evo-
lutionarily conserved parts of the promoters. This makes
sense if selection against co-occurrence results in dis-
ruption of the respective TFBS as this ultimately would
result in a degenerated sequence and no sequence con-
servation. Such selection could possibly act to minimize
contradicting regulatory signals caused by, e.g., spurious
expression of transcription factor genes, or to keep dif-
ferent cellular states/processes well separated from a
regulatory point of view. The target genes for the
respective TFBS clusters represented in almost all cases
biologically coherent sets of genes, as determined by
GO term enrichment analyses or the Ingenuity software,
and represented highly divergent cellular processes.
Hence, we conclude that the identified TFBS clusters,
and their associated gene signatures, are of biological
relevance.
We are aware of several limitations of the above ana-
lyses. For instance, the most appropriate way to identify
Figure 8 Identification of correlated TFBS as identified using the -5000,+1000 portions of the promoters and phylogenic foot printing.
A hierarchical cluster analysis with adjoined heat map of correlations of the portion of the TFBS that showed sizeable correlations and indicated
in Additional file 7, Figure S6.
Veerla et al. BMC Genomics 2010, 11:145
http://www.biomedcentral.com/1471-2164/11/145
Page 12 of 17TFBS that co-regulate genes might not be to investigate
global correlation as this measure includes mutual
absence in the comparison. An alternative measure of
similarity could have been the Jaccard algorithm [14].
We also applied the same thresholds for all clusters
when selecting genes associated with the specific TFBS
clusters, the top 2000 and 1300 respectively. As the
number of promoters positive for a given TFBS varies
with the particular TFBS, an alternative selection criter-
ion would have been to select a given fraction of the
positive promoters (genes), e.g., the top 80% of the posi-
tive genes, as associated with the signature, which would
have produced target gene lists of varying sizes; an
option that could easily be biologically motivated. As an
alternative to the sum of the normalized hits used in the
preset investigation various Boolean conditions could
Table 2 GO category analysis of TFBS cluster gene signatures.
Signature Gene Category EASE score
CREB_VJUN nucleobase\, nucleoside\, nucleotide and nucleic acid metabolism 6.03E-12
CREL_NFKB immune response 2.06E-07
HMGIY_STAT Ns ns
IK1_RBPJK nucleobase\, nucleoside\, nucleotide and nucleic acid metabolism 8.57E-06
ETS_TEL2 Ns ns
CETS_E2F4 nucleobase\, nucleoside\, nucleotide and nucleic acid metabolism 4.13E-20
NGFC_EGR Ns ns
HELIOSA_GLI intracellular signaling cascade 1.21E-06
LBP1_HEB Ns ns
AML response to biotic stimulus 3.85E-10
PITX2_AP2 protein metabolism 3.07E-05
AREB6_E12 Ns ns
MYC Ns ns
GC_WHN regulation of transcription 3.67E-16
MAZR_IK regulation of transcription\, DNA-dependent 7.14E-29
TEF1_BACH response to external stimulus 4.19E-16
DBP_GATA response to external stimulus 1.14E-18
FREAC_HFH response to external stimulus 5.39E-07
Figure 9 Identified clusters of TFBS using the -5000,+1000 portions of the promoters and phylogenic foot printing. Color codes listed
in the order left to right as in the dendrogram in Figure 8.
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Nevertheless, most of the identified TFBS gene signa-
tures were associated with coherent cellular processes
and made biological sense. To facilitate future investiga-
tions we will provide the software used in this available
at http://cbbp.thep.lu.se/~markus/software/SMART/.
Conclusions
We have provided a flexible tool to produce TBFS/pro-
moter databases. We have described a approach to iden-
tify significant TFBS in gene sets by use of a resampling
strategy and the introduction of a new measure of sig-
nificance, significantly present (PP). We apply this
approach to several published ChIP-Chip data and
curated gene signatures obtained from MSigDB and
show that the strategy produces consistent results and
hence may be useful in the analysis of gene expression
profiles or ChIP-Chip data. In addition, we have shown
that TFBS form stable clusters of co-occurring TFBS
that in a consorted fashion seems to regulate sets of
genes associated with highly specific cellular processes.
Methods
Data sets
We selected published ChIP-Chip data sets for valida-
tion using the criteria that the data should be easy to
access and that approximate positions of the binding
sites relative the TSS of the genes were available. For
E 2 F 4 ,N A N O G ,a n dO C T 4C h I P - C h i pt a r g e tg e n e sw e
used the data provided by Boyer et al. [15], named BOY-
ER_E2F4, BOYER_NANOG, and BOYER_OCT4 in the
present investigation. We also included a list of genes
that by ChIP-Chip analysis were shown to simulta-
n e o u s l yb i n dN A N O G ,O C T 4 ,a n dS O X 2p r o v i d e db y
Boyer at al., BOYER_NANOG_OCT4_SOX2. The ana-
lyses were limited to genes that contained targets within
8 kb upstream of the TSS. ChIP-Chip data from Xu
et al. [16] were used to produce a list of genes
(XU_E2F) with strong E2F binding. For MYC ChIP-
C h i pt a r g e tg e n e sw eu s e dd a t ap r o v i d e db yZ e l l e re ta l .
[17] but only included genes with 5’ locations of ChIP-
Chip targets (ZELLER_MYC). Only genes with reported
ChIP-Chip targets within the -1500 to TSS region were
included. For analyses of HNF6 target genes in hepato-
cytic and pancreatic cells the data provided by
Odom et al. [18] was used (ODOM_HNF6_Hepa and
ODOM_HNF6_Panc). TP53 ChIP-Chip target genes
were obtained from the Smeenk et al. [11] ChIP-Chip
data (SMEENK_TP53). Two SMEENK_TP53 data sets
were produced, one including genes with ChIP-Chip tar-
gets within the -1500 to +500 promoter segment and
one including genes with targets within the -5000 to
+1000 promoter segment. Curated gene sets for various
conditions were obtained from the MSigDB database
[19]. Gene set designations are the same as in the
MSigDB database. Gene signatures for MYC and E2F3
were obtained from Bild et al. [20], BILD_MYC and
BILD_E2F3, respectively.
Table 3 The twelve largest clusters of TFBS formed after QT-clust analysis
QTCluster_1 QTCluster_2 QTCluster_3 QTCluster_4 QTCluster_5 QTCluster_6
NKX62 USF GC CKROX CREB LMO2COM
OG2 CLOCKBMAL ETF SPZ1 ATF AREB6
FOXO4 HIF1 AP2GAMMA WT1 CREBP1CJUN E47
FOXO1 NMYC MOVOB MZF1 ATF4 E2A
BCL6 ARNT AP2 MAZ ATF3 MYOD
SOX10 USF2 LRF TFIII CREBP1 E12
STAT5A MYCMAX CHCH IK
S8 MAX SP1
SRY MYC AP2ALPHA
PAX2 EBOX
STAT4
CDXA
TBP
QTCluster_7 QTCluster_8 QTCluster_9 QTCluster_10 QTCluster_11 QTCluster_12
HNF3ALPHA GATA LBP1 AML HELIOSA CETS1P54
FOXJ2 GATA6 AP4 COREBINDINGFACTOR ETS SAP1A
FOXO3A GATA3 TAL1 PEBP IK1 ELK1
HNF3B GATA2 MYOGENIN OSF2 STAT3 NRF2
HFH3 GATA1 HEB AML1
HNF3 RUSH1A
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We used hierarchical clustering with 1-Pearson as a dis-
tance measure and average-linkage for agglomeration in
the initial analyses. Groups of TFBS that behaved simi-
larly were identified by manual inspection. We also used
the more stringent QT Clust (Quality Cluster algorithm)
modified from Heyer et al. [21]. QT Clust proceeds by
forming a candidate cluster with the first TFBS as a seed
and grouping TFBS’s with the highest correlation itera-
tively in a way that minimizes the cluster diameter d,
until no further genes may be added without exceeding a
predetermined d-value. This procedure is performed with
all TFBS in the data set as a seed. The largest cluster is
then retrieved and the procedure repeated with the
remaining TFBS on the list until no further clusters may
be formed. This makes sure that the largest and most
coherent clusters of TFBS are formed. We used a thresh-
old diameter of 0.5 based on Pearson correlation and a
minimal cluster size of 2 members. Identified TFBS clus-
ter gene signatures were evaluated either with the EASE
[22] or the Ingenuity software [23]. To produce gene sig-
natures for groups of correlated TFBS we first normalized
the number of hits per promoter by dividing with the
total number of detected hits for each TFBS. Then the
sum of the normalized hits for gene members in a given
TFBS cluster was calculated for each gene promoter, and
finally the genes were ranked according the sum of nor-
malized hits. This produced gene lists composed of 18
377 genes using the TFBS/promoter database based on
the -1500 to +500 genomic intervals and 13 177 when
using the phylogenetic foot printing approach, in which
the top ranking genes will have the largest number of
normalized hits for binding sites in their promoters.
Additional file 1: Figure S1. Promoter analysis of genes binding
NANOG, OCT4, and TP53 as determined by ChIP-Chip analyses.A l l
results based on 10
5 re-samples for estimations of PE and PP a) analysis
of promoters of NANOG binding genes using phylogenic foot printing of
the -5000,+1000 portions of the promoters. b) Analysis of promoters of
OCT4 binding genes using phylogenic foot printing of the -5000,+1000
portions of the promoters. All TBFS names having PE values equal to 5
except NANOG, OCT, OCT1, and OCT4 omitted from the graph for clarity.
c) Analysis of promoters of TP53 binding genes using the -1500,+500
portions of the promoters. d) Analysis of promoters of TP53 binding
genes using phylogenic foot printing of the -5000,+1000 portions of the
promoters.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
145-S1.PDF]
Additional file 2: Figure S2. Promoter analysis of genes binding
MYC as determined by ChIP-Chip analysis. a) Analysis of promoters of
all MYC binding genes in the ZELLER_MYC data. b) Analysis of promoters
of MYC binding genes lacking EBOXes c) Analysis of promoters of MYC
binding genes with EBOXes. d) Analysis of promoters of MYC binding
genes with EBOXes using 10
6 instead of 10
5 re-samples to compute PE
and PP.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
145-S2.PDF]
Table 4 The ten most coherent TFBS-cluster gene
signatures according to the Ingenuity software
a
p-value
GC, ETF, AP2GAMMA, MOVB, AP2, LRF, CHCH, SP1,
AP2LAPHA
Cellular Development (MCF) 4.32E-13
Organ Development (PSDF) 2.43E-14
Wnt/b-catenin Signaling(CP) 3.90E-10
CKROX, SPZ1, WT1, MZF1, MAZ, TFIII, IK
Cellular Development (MCF) 3.97E-12
Tissue Development (PSDF) 1.23E-12
Wnt/b-catenin Signaling (CF) 1.51E-05
AML, COREBINDINGFACTOR, PEBP, OSF2, AML1
Cell-To-Cell Signaling and Interaction (MCF) 5.29E-05
Hematological System Development and Function (PSDF) 3.08E-05
Immune Cell Trafficking (PSDF) 3.08E-05
CACBINDINGPROTEIN, CACD, PAX4, SREBP1
Cellular Development (MCF) 6.48E-12
Organismal Development (PSDF) 4.92E-16
Axonal Guidance Signaling (CP) 4.26E-05
HMGIY, STAT6, STAT1, NFAT
Cellular Development (MCF) 2.43E-08
Nervous System Development and Function (PSDF) 6.45E-18
Axonal Guidance Signaling (CF) 4.24E-04
CEBPDELTA, CEBPB, CEBPA
Antigen Presentation (MCF) 4.28E-04
Humoral Immune Response (PSDF) 2.98E-04
T Helper Cell Differentiation (CP) 1.61E-03
ZF5, E2F, KROX
Gene Expression (MCF) 6.32E-22
Organ Development (PSDF) 5.59E-16
Axonal Guidance Signaling (CP) 1.13E-12
ZTA, BACH2, BACH1
Antigen Presentation (MCF) 1.35E-06
Cell-mediated Immune Response (PSDF) 1.35E-06
NF-kB Signaling (CP) 1.71E-03
CREL, NFKAPPAB65
Cell-To-Cell Signaling and Interaction (MCF) 2.73E-05
Cell-mediated Immune Response (PSDF) 1.81E-06
NF-kB Signaling (CP) 4.28E-06
MAZR, ZNF219
Cellular Development (MCF) 9.61E-13
Nervous System Development and Function (PSDF) 1.23E-10
Axonal Guidance Signaling (CP) 1.40E-07
a Only the top categories with respect to p-value are given
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Page 15 of 17Additional file 3: Figure S3. Promoter analysis of MYC gene
signatures obtained from MSigDB, using the -5000,+1000 portions
of the promoters, phylogenic foot printing, and 10
5 re-samples for
estimations of PE and PP. a) Results for the FERNANDEZ_MYC_TARGETS
signature. b) Results for the MYC_ONCOGENE_SIGNATURE signature. c)
Results for the MYC_TARGETS signature. d) Results for the LEE_MYC_UP
signature. All signature designations are as in MSigDB.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
145-S3.PDF]
Additional file 4: Figure S4. Promoter analysis of hypoxia related
gene signatures obtained from MSigDB, using phylogenic foot
printing and 10
5 re-samples for estimations of PE and PP. a) Results
for the MENSE_HYPOXIA_UP signature. b) Results for the HIF_TARGETS
signature. c) Results for the HYPOXIA_NORMAL_UP signature. d) Results
for the MANALO_HYPOXIA_UP signature. All signature designations are
as in MSigDB.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
145-S4.PDF]
Additional file 5: Figure S5. Analysis of correlations among TFBS
obtained using the -1500,+500 portions of the promoters. Heat map
obtained after reorganization with hierarchical cluster analysis. The
portion of TFBS used for further analyses in box.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
145-S5.PDF]
Additional file 6: Table S1. GO category analysis of TFBS cluster
gene signatures obtained after hierarchical cluster analysis using
the -1500,+500 portions of the promoters. Bonferroni corrected EASE
scores < 0.05 considered significant.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
145-S6.XLS]
Additional file 7: Figure S6. Analysis of correlations among TFBS
obtained using the -5000,+1000 portions of the promoters and
phylogenic foot printing. Heat map obtained after reorganization with
hierarchical cluster analysis. The portion of TFBS used for further analyses
in box.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
145-S7.PDF]
Additional file 8: Table S2. GO catagory analysis of TFBS cluster
gene signatures obtained after hierarchical cluster analysis using
the -5000,+1000 portions of the promoters and phylogenic foot
printing. Bonferroni corrected EASE scores < 0.05 considered significant.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
145-S8.XLS]
Additional file 9: Table S3. List of all 58 TFBS clusters formed after
QT-clust analysis.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
145-S9.XLS]
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